Methods and devices for improving cardiac function in hearts

Abstract

Various methods and devices are disclosed for improving cardiac function in hearts having zones of infarcted (akinetic) and aneurysmal (dyskinetic) tissue regions. The methods and devices reduce the radius of curvature in walls of the heart proximal infarcted and aneurysmal regions to reduce wall stress and improve pumping efficiency. The inventive methods and related devices include splinting of the chamber wall proximal the infarcted region and various other devices and methods including suture and patch techniques.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. patent application Ser. No. 09 / 124,286 filed Jul. 29, 1998, now pending, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 933,456 filed Sep. 18, 1997, now pending, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 778,277, filed Jan. 2, 1997, now pending.FIELD OF THE INVENTION [0002] The present invention pertains to the field of apparatus for treatment of a failing heart. In particular, the apparatus and its related methods of the present invention is directed toward reducing the wall stress in the failing heart. The present invention further includes methods and devices for improving cardiac function in hearts having discrete zones of infarcted tissue. Such methods and devices reduce the radius of curvature and / or alter the geometry or shape of the infarcted tissue and adjacent regions to thereby reduce wall stress on the heart and improve th...

AI Technical Summary

Benefits of technology

"The present invention provides a non-invasive method for treating heart failure due to dilatation, infarction, or aneurysm by reducing the tension in the heart wall. The invention involves the use of a splint or splints that can be placed in the heart chamber to decrease the energy consumption of the failing heart. The splint can be a full cycle splint that engages the heart wall throughout the cardiac cycle or a restrictive splint that only engages at end systole. The splint can be a tension member or a compression member, and can be used alone or in combination with other surgical techniques. The invention offers an improved method for treating heart failure that is less invasive, poses less risk to the patient, and is likely to be more clinically effective."

Problems solved by technology

Typically these processes result in dilatation of the left ventricular chamber.

With damage to the myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate.

The basic problem with a large dilated left ventricle is that there is a significant increase in wall tension and / or stress both during diastolic filling and during systolic contraction.

However, in a failing heart, the ongoing dilatation is greater than the hypertrophy and the result is a rising wall tension requirement for systolic contraction.

This is felt to be an ongoing insult to the muscle myocyte resulting in further muscle damage.

Additionally, because of the lack of cardiac output, there is generally a rise in ventricular filling pressure from several physiologic mechanisms.

These drug therapies offer some beneficial effects but do not stop the progression of the disease.

Heart transplantation has serious limitations including restricted availability of organs and adverse effects of immunosuppressive therapies required following heart transplantation.

However, this extremely invasive procedure reduces muscle mass of the heart.

The bulge resulting from an aneurysm can have several serious effects on the heart and its performance that can lead to in both morbidity and mortality.

Another serious effect this bulging can have is the denigration of the heart's pumping function.

The aneurysmal bulge creates problems with pumping function in at least three ways.

This further increases the contractile requirement of the remaining functional myocardium.

Second, the aneurysmal bulge alters the geometry of the entire ventricular chamber.

Third, over time, the above two conditions lead the functional muscle of the ventricle to work harder than normal.

This can lead to continued dilatation of the ventricle, increasing tension in the walls of the heart, with increased myocardial oxygen requirement and further progressing heart failure.

Typically, the result is the entire ventricle increasing in size, which increases wall stress.

Again, since the functioning myocardium must work harder, continuing progression of heart failure can occur.

If the infarcted or aneurysmal region is located in the vicinity of the mitral valve, geometric abnormalities may cause the mitral valve to alter its normal position and dimension, and may lead to annular dilatation and the development of mitral regurgitation.

Over time, these effects can continue to lead to progression of heart failure.

Images